Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 06:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study
NCT02219373 · Boston Children's Hospital · PHASE3 · withdrawn · last registry update 2026-10-08 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Study was withdrawn for feasibility-related concerns.” | – | Registry record, Boston Children's Hospital |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CACNA1H within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-11-04Phase 3 first posted: Assiut University, treatment of Postdural puncture headache (NCT07916116)
- 2026-09-24Also stopped (withdrawn): George Washington University, Bupivacaine + Exparel + Bupivacaine (NCT07221019)
- 2026-07-07Results posted on the registry: University of Kansas Medical Center, Tylenol + Oxycodone (NCT04246697)
- 2026-06-04Phase 3 first posted: Rehman Medical Institute - RMI, oxcarbamezapine(300 mg twice daily) + combination therapy(oxcarbamezapine 300 mg twice daily and gabapentine) (NCT07625410)
- 2026-06-03Results posted on the registry: Mayo Clinic, Oxycodone + Ibuprofen (NCT05076110)
- 2026-04-16Results posted on the registry: Roswell Park Cancer Institute, Gabapentin + Methadone (NCT03574792)
- 2026-04-01Results posted on the registry: Jocelyn Fitzgerald, Multimodal Bundle Drugs + Bladder Instillation (NCT05658874)
- 2026-04-01Also stopped (terminated): Jocelyn Fitzgerald, Multimodal Bundle Drugs + Bladder Instillation (NCT05658874)
- 2026-03-19Results posted on the registry: Henry Ford Health System, Celecoxib + Hydrocodone-Acetaminophen (NCT03818932)
- 2026-02-24Phase 3 first posted: Mansoura University, solifenacin combined with gabapentin + solifenacin monotherapy (NCT07429734)
- 2026-01-20Phase 3 first posted: Assiut University, Valacyclovir + Paracetamol (Acetaminophen) + Gabapentin (standard medical therapy) (NCT07349680)
- 2026-01-06Results posted on the registry: CAMC Health System, Pregabalin 50mg + Gabapentin 300mg (NCT04705480)
- 2025-12-22Phase 3 first posted: University of California, San Francisco, Pharmacologic Pain Management (NCT07296770)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision